alpha receptor

(redirected from adrenergic receptor)
Also found in: Dictionary, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.
Related to adrenergic receptor: cholinergic receptor
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for alpha receptor

receptors postulated to exist on nerve cell membranes of the sympathetic nervous system in order to explain the specificity of certain agents that affect only some sympathetic activities (such as vasoconstriction and relaxation of intestinal muscles and contraction of smooth muscles)

References in periodicals archive ?
Keywords: Tyramine; [beta]-phenylethylamine; Adrenergic receptor [beta]2; molecular docking; Molecular dynamics simulation
It contains a beta-3 adrenergic receptor agonist combined with hyaluronic acid, a substance naturally found in the human body and commonly used in products like skin moisturisers.
Olanzapine has the lowest affinity for adrenergic receptors (16).
Hancock reported presence of [alpha] adrenergic and [beta] adrenergic receptors in human ureter.
45) The molecular sizes of the [beta] adrenergic receptor and adenylate cyclase were estimated to be 75,000 and 220,000, respectively.
The combination of [mu] opioid receptor agonists (MRA) with inhibitors of the norepinephrine reuptake (INR) or with [alpha]2 adrenergic receptor agonists, has been observed to produce analgesia after their intrathecal or systemic administration in models of nociceptive and neuropathic pain.
The extended-release form of the drug, a selective alpha-2A adrenergic receptor agonist, previously had been approved as monotherapy for treating ADHD.
1] adrenergic receptor gene polymorphisms are shown in Table II and also compared with other major populations.
Cloning and expression of a human kidney cDNA for an alpha-2 adrenergic receptor subtype.
The extended-release form of the drug is a selective alpha-2A adrenergic receptor agonist and was first approved for the treatment of hypertension in 2002, and for ADHD in 2007.
Intuniv, a once-daily formulation of guanfacine, is said to be the first selective alpha-2A adrenergic receptor agonist approved for the treatment of ADHD.
Full browser ?